Browsing publications of the research group drug design and optimization(HIPS]DDOP) by Journal
Now showing items 1-1 of 1
Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection.The liver contains large amounts of microRNA-122 (miR-122), whereas other tissues contain only marginal amounts of this miRNA. MicroRNAs have also been found to circulate in the blood in a cell-free form; their potential as readily accessible disease markers is currently evaluated. Here, we investigated if the serum levels of miR-122 might be useful as disease parameter in patients with chronic hepatitis C virus (HCV) infection.